The pharmacokinetics of valacyclovir in immunocompromised children.

被引：0
|
作者：
Bomgaars, L
Duran, C
Khan, S
Berg, S
Blaney, S
机构：
[1] Baylor Coll Med, Pediat Pharmacol Res Unit, Houston, TX 77030 USA
[2] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P15 / P15
页数：1
相关论文
共 50 条
  • [21] Multiple-dose safety and pharmacokinetics of ezetimibe in adolescent children.
    Kosoglou, T
    Kakkar, T
    Statkevich, P
    Anderson, L
    Pai, S
    Boutros, T
    Veltri, EP
    Affrime, MB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P52 - P52
  • [22] Population pharmacokinetics of an oral solution of mizolastine, a new antihistamine in children.
    Dubruc, C
    Mentré, F
    Chaufour, S
    Scheinmann, P
    Dab, I
    Pinquier, JL
    Rosenzweig, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 96 - 96
  • [23] Continuous infusion pralidoxime in the treatment of organophosphate intoxication: Pharmacokinetics in children.
    James, L
    Schexnayder, S
    Farrar, H
    Wells, T
    Kearns, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : OIII4 - OIII4
  • [24] Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy
    Kimberlin, DF
    Weller, S
    Whitley, R
    Andrews, WW
    Hauth, JC
    Lakeman, F
    Miller, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (04) : 846 - 851
  • [25] Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection
    Neant, Nadege
    Klifa, Roman
    Bouazza, Naim
    Moshous, Despina
    Neven, Benedicte
    Leruez-Ville, Marianne
    Blanche, Stephane
    Treluyer, Jean-Marc
    Hirt, Deborah
    Frange, Pierre
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2422 - 2429
  • [26] FAVIPIRAVIR PHARMACOKINETICS IN IMMUNOCOMPROMISED INFANTS AND CHILDREN WITH CHRONIC RNA VIRAL INFECTIONS
    Johnson, Trevor
    Kondowe, Fiskani
    Gardner, Iain
    ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (06) : A7 - A8
  • [27] Pharmacokinetics and safety of transdermal oxybutynin for treatment of neurogenic bladder in adults and children.
    Hill, L. A.
    Cartwright, P. C.
    Kennelly, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S92 - S92
  • [28] Severe, acute neurotrauma alters phenytoin (DPH) pharmacokinetics (PK) in children.
    Stowe, CD
    Storgion, SA
    Lee, KR
    Phelps, KJ
    PEDIATRIC RESEARCH, 1996, 39 (04) : 463 - 463
  • [29] Comparison of fentanyl pharmacokinetics and dose-determining factors in adults and children.
    Lim, Sin Yin
    Johnson, Peter
    Miller, Jamie
    Woo, Sukyung
    PHARMACOTHERAPY, 2014, 34 (10): : E290 - E291
  • [30] Pharmacokinetics (PK) of continuous infusion furosemide (FI) in critically ill children.
    Eades, SK
    Quasney, MW
    Ring, JC
    Wilson, MB
    Mottern, RK
    Christensen, ML
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 31A - 31A
12345